Bayer plan to launch GMO dicamba-resistant soybean in Brazil sparks pushback from some farmers

RRSoybeansExtend

A genetically modified soy seed technology from Germany’s Bayer set to launch soon in Brazil has sparked concern from some farmers who worry that other crops could be impacted by dicamba, a herbicide the biotech product is designed to tolerate.

Widely used in the United States, dicamba has been described by farmers who have applied it as a volatile product that drifts off easily. As such, it may compromise non-tolerant soybeans, growers told Reuters.

“When dicamba lands on plants that haven’t been designed to resist it, those plants struggle,” said Cayron Giacomelli, a farmer and agronomist. “Dicamba is highly harmful to materials other than Xtend,” Giacomelli said.

Bayer makes the “INTACTA 2 XTEND” seed technology, which allows the genetically modified soybeans to be treated with dicamba without being harmed. Dicamba is used to control broadleaf weeds in grain crops, according to Cornell University.

Bayer is planning to launch Xtend in Brazil in the 2021/2022 crop cycle. It said on [September 30] that Xtend combines biotechnology with new crop protection tools to boost farmer yields “to a new level.”

Read full, original article: Brazil grain growers wary of dicamba as Bayer launches new GM soy seed

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot 2025-07-30 at 10.48
Can gene editing eliminate Down syndrome? Scientists have done it in lab-grown cells
Screenshot 2026-05-26 at 10.15
Viewpoint: Double standard—Why does the wellness industry get a free pass while Big Healthcare is treated as morally suspect?
ChatGPT-Image-Jun-4-2026-01_27_58-PM
Viewpoint—N.A.D.+: Why Gwenyth Paltrow’s heralded anti-aging supplement doesn’t work
ChatGPT-Image-May-26-2026-07_51_21-AM-2
Viewpoint: There are more than 1,000 chemicals in a cup of coffee—including many substances that can cause cancer. Why isn’t it banned?
downsyndrome_compilation_MID_1
CRISPR breakthrough that can remove the chromosome responsible for Down syndrome raises ethical questions
ChatGPT-Image-Jun-4-2026-11_49_36-AM-2
‘You don’t understand Tolkien’: Skeptic Pope trolls tech giants about the exaggerated, risk-less benefits of AI
tick-DNA
GLP podcast: Spread meat allergy with gene-edited ticks? Bioethicists pose vile ‘thought experiment’

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.